Avista Healthcare
New York, NY, October 17, 2007 – Avista Capital Partners, a leading private equity firm, today announced that it has hired Charles C. Harwood, Jr., a proven operator in the clinical diagnostics and pharmaceutical services industries, and Ron Sparks, a 30-year veteran of the medical device industry, as Healthcare Industry Advisors. Mr. Harwood, 54, currently […]
New York, NY, June 13, 2007 – Avista Capital Partners, a leading middle market focused private equity firm, announced today that it has completed the final closing of its first private equity fund, Avista Capital Partners, L.P. (the “Fund”). The Fund was substantially oversubscribed, and closed with total commitments of $2.0 billion. The Fund had […]
New York, NY, April 12, 2007 – Avista Capital Partners, a leading private equity firm, announced today it has completed its acquisition of BioReliance Corporation, a business unit of Invitrogen Corporation (NASDAQ: IVGN) for approximately $210 million. BioReliance is a leading contract service organization providing biological safety testing, toxicology, viral manufacturing, and laboratory animal diagnostic […]
New York, NY, February 13, 2007 – Avista Capital Partners, a leading private equity firm, announced today it has signed a definitive agreement to acquire BioReliance Corporation, a business unit of Invitrogen Corporation (NASDAQ: IVGN) for approximately $210 million. BioReliance is a leading contract service organization providing biological safety testing, toxicology, viral manufacturing, and laboratory […]
New York, NY, October 10, 2006 – Avista Capital Partners, a leading private equity firm, today announced it has committed to purchase up to €125 million of common stock in Nycomed A/S (“Nycomed”). Based in Roskilde, Denmark, Nycomed is a mid-size pharmaceutical company focused on the sale of branded prescription and over-the-counter drugs in the […]
Houston, TX, October 3, 2006 – PRNewswire — Avista Capital Partners, a leading private equity firm, today announced it has committed to purchase up to $50 million in MedServe, Inc. to fund a national consolidation of small operators in the medical waste industry. Based in Houston, Texas, MedServe provides medical waste removal and destruction and […]
HAMILTON, Bermuda, September 21, 2006 – PRNewswire-FirstCall — Warner Chilcott Limited today announced the pricing of its initial public offering of 70,600,000 shares of common stock, at a price of $15 per share. The shares will be listed on the Nasdaq Global Select Market and will trade under the symbol “WCRX” beginning September 21, 2006. […]
Lyndhurst, NJ, and Herndon, VA, May 19, 2006 – PRNewswire-FirstCall — Quest Diagnostics Incorporated , the nation’s leading provider of diagnostic testing, information and services, has agreed to acquire Focus Diagnostics, Inc., the premier infectious disease testing provider, in a cash transaction valued at approximately $185 million. Focus Diagnostics is privately held and based in […]